Skip to content

Public FDA record

Z-2113-2014: InSite HER-2 Detection Kit, an immunohistochemistry assay for in vitro diagnostic use.

Recall record Z-2113-2014 for Biogenex Laboratories, Inc.. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2113-2014
Company in FDA record
Biogenex Laboratories, Inc.
FDA classification date
Jul 24, 2014
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Product was distributed without 510(k) approval.

Source facts

Action
Each customer contacted by phone - neither is in possession of the product.
Initiated
2014-07-01
Root cause
No Marketing Application
Terminated
2014-07-24
Distribution
Brazil and Ecuador. No US distribution
Recall number
Z-2113-2014
Recall status
Terminated
CDRH record ID
128488
FDA classified
2014-07-24
Recall event number
68709

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗